Overview

L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this research is to evaluate the effects of L-glutamine as a therapy for sickle cell anemia and sickle ß0-thalassemia. as evaluated by the number of occurrences of sickle cell crises.
Phase:
Phase 2
Details
Lead Sponsor:
Emmaus Medical, Inc.
Collaborator:
FDA Office of Orphan Products Development